Table 2.
Outcomes from Phase 1 Interventions: Compliant (CPAP Use ≥4 H/day) vs. Noncompliant (CPAP Use <4 H/day)
| CPAP ≥4 h/day | CPAP <4 h/day | |
|---|---|---|
| N | 49 (24%) | 155 (76%) |
| Daily use @ 2 weeks (hr) | 5.8 ± 1.4 * | 1.9 ± 1.3 |
| % Days used @ 2 weeks | 93.9 ± 30.2 | 62.6 ± 42.1 |
| Age (y) | 52.0 ± 12.2 | 54.6 ± 12.3 |
| Male (%) | 60 | 66 |
| Bmi (kg/m2) | 34.3 ± 8.9 | 34.0 ± 8.1 |
| Previous AHI (events/h) | 42.2 ± 28.0 | 40.6 ± 30.5 |
| Prescribed CPAP (cm h2o) | 9.1 ± 2.6 | 9.1 ± 2.2 |
| Days from initial diagnosis (median; interquartile range) | 134 (53; 367) | 112 (64; 274) |
| Estimated entry use (h/day) | 2.1 ± 1.1 | 2.0 ± 1.1 |
| Changed mask | 11 (23%) | 65 (43%) * |
| Added heated humidity | 6 (13%) | 30 (20%) |
| Added nasal steroids | 15 (31%) | 54 (36%) |
| No intervention | 22 (45%) | 53 (34%) |
| One intervention | 19 (39%) | 63 (41%) |
| Two interventions | 7 (14%) | 32 (21%) |
| Three interventions | 1 (2%) | 7 (4%) |
Values are mean ± standard deviation, excepting days from initial diagnosis (non-normal distribution).
*
p < 0.0001